相关实验视频

Updated: Sep 15, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.4K

·维勒布兰德因子在ECMO:一个动态调节器的出血和血栓形成

Lingjuan Liu1, Shanshan Chen, Dingji Hu1

  • 1Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.

Shock (Augusta, Ga.)
|July 15, 2025
PubMed
概括

在体外膜氧化 (ECMO) 过程中,Von Willebrand因子 (vWF) 功能障碍有两个阶段:初始凝血,然后出血. 目前的抗凝血药不够,需要新的管理策略.

关键词:
ADAMTS13A 分解蛋白和金属蛋白酶具有血栓素1型动机.AIM自抑制模块自动抑制模块Ang-2angiopoietin-2的使用方法ApoA-I阿波利波蛋白 A-I-I 是一种阿维斯获得了·维勒布兰德综合征.COVID-19 冠状病毒疾病 2019 年在DDAVP下,压力下降.在ECMO体外膜氧化.在ECs内皮细胞.FFP新鲜冷等离子体没有FHB的血红蛋白.FVIII第八个因子GPIbαglycoprotein Ibα 是一种葡萄糖蛋白.在GPVI葡萄糖蛋白VI.HMW-vWF高分子量维勒布兰德因子LRR富含氨酸的重复重复.左心室辅助装置 (LVAD) 是一种左心室辅助装置.MSD机械敏感领域NPSS非生理学剪切应力.PDvWF血衍生威勒布兰德因子PI3K-AktSARS-CoV-2严重急性呼吸系统综合征冠状病毒2在TM−/−中缺乏血栓模块素.在TSP-1血栓素-1中.ULvWF超大维勒布兰德因子在VA-ECMOvenoarterial外体膜氧化过程中.VV-ECMO静脉静脉外体膜氧化·维勒布兰德因素是什么WPBs 韦贝尔 - 帕拉德机构获得的·维勒布兰德综合征身体外膜氧化氧化血液静止 血液静止 血液静止成员 13 成员 13rvWF复合维勒布兰德因子血栓形成的原因是血栓形成.威勒布兰德病的vWDvon 威勒布兰德病vWF:AgvWF 抗原 的 抗原vWF:CBvWF的原结合活动活动.vWFvon Willebrand因子 的使用情况.

更多相关视频

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.3K

相关概念视频

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
917
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.9K